We are live on ! Find out more
TECH icon

Bio-Techne

248 hedge funds and large institutions have $3.38B invested in Bio-Techne in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 88 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

5% more funds holding

Funds holding: 237248 (+11)

2% more capital invested

Capital invested by funds: $3.32B → $3.38B (+$57.8M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 88

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $187K

Holders
248
Holders Change
+11
Holders Change %
+4.64%
% of All Funds
7.2%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
29
Increased
87
Reduced
88
Closed
16
Calls
Puts
$187K
Net Calls
-$187K
Net Calls Change
-$187K
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
51
Principal Financial Group
Iowa
$9.82M +$1.36M +57,836 +16%
BIM
52
BlackRock Investment Management
Delaware
$9.72M +$854K +36,440 +10%
Prudential Financial
53
Prudential Financial
New Jersey
$9.47M -$404K -17,216 -4%
STC
54
SEI Trust Company
Pennsylvania
$9.09M +$977K +41,696 +12%
RSCM
55
Rail-Splitter Capital Management
Illinois
$9.01M -$1.85M -78,900 -17%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$8.89M +$9.38K +400 +0.1%
EAM
57
Edge Asset Management
Washington
$8.47M +$141K +6,000 +2%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$7.99M -$864K -36,880 -10%
Charles Schwab
59
Charles Schwab
California
$7.98M +$395K +16,856 +5%
Morgan Stanley
60
Morgan Stanley
New York
$7.93M +$2.56M +109,412 +48%
Barclays
61
Barclays
United Kingdom
$7.89M -$1.35M -57,540 -15%
CS
62
Credit Suisse
Switzerland
$7.83M -$1.21M -51,804 -13%
State Farm Mutual Automobile Insurance
63
State Farm Mutual Automobile Insurance
Illinois
$7.52M
CM
64
Castleark Management
Illinois
$7.49M +$8.22M +350,840 New
PAMP
65
Polar Asset Management Partners
Ontario, Canada
$7.45M
Dimensional Fund Advisors
66
Dimensional Fund Advisors
Texas
$7.27M +$141K +6,024 +2%
AIG
67
American International Group
New York
$6.93M +$685K +29,240 +11%
PNC Financial Services Group
68
PNC Financial Services Group
Pennsylvania
$6.83M +$223K +9,504 +3%
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$6.5M +$41.3K +1,764 +0.6%
New York State Teachers Retirement System (NYSTRS)
70
New York State Teachers Retirement System (NYSTRS)
New York
$6.33M
Millennium Management
71
Millennium Management
New York
$5.81M +$2.85M +121,600 +96%
Robeco Institutional Asset Management
72
Robeco Institutional Asset Management
Netherlands
$5.66M
EAM
73
Eagle Asset Management
Florida
$5.58M -$113K -4,804 -2%
GC
74
Guggenheim Capital
Illinois
$5.43M +$21.6K +920 +0.4%
SCM
75
Snyder Capital Management
California
$5.24M -$2.11M -89,920 -29%

TECH Hedge Fund Activity: Q3 2014 in Review

248 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2014, worth a combined $3.38B — up 1.7% from $3.32B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TECH positions and 16 closed out — a net gain of 13 holders — while 87 added to existing stakes and 88 trimmed.

The largest buyer was Invesco, adding an estimated $33.3M. The largest seller was Norges Bank, cutting an estimated $27.8M.

  • 248 institutional investors held Bio-Techne (TECH) as of Q3 2014, up from 237 in Q2 2014.
  • Funds reported $3.38B of Bio-Techne stock for Q3 2014, up 1.7% quarter-over-quarter.
  • 29 funds opened new Bio-Techne positions in Q3 2014 and 16 closed out, a net change of +13 holders.
  • The largest Bio-Techne buyer in Q3 2014 was Invesco, an estimated $33.3M added.
  • The largest Bio-Techne seller in Q3 2014 was Norges Bank, an estimated $27.8M sold.

Based on aggregated 13F filings for Q3 2014.